Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Feng, NJ
Chang Feng, Belle Mead, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120066596 | System And Method For Video Communication On Mobile Devices - A video teleconferencing system which allows a mobile device to conduct teleconferences over fixed and mobile packet networks with end points with other mobile devices or a personal computer. The mobile device includes a user interface that displays a video image associated with a first participant. A selectable user interface element corresponding to a second participant video image may be displayed on the user interface and in response to selection of the selectable user interface element, a video image associated with the second participant may be displayed. | 03-15-2012 |
Chang Feng, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080215669 | System and Method for Peer-to-Peer Connection of Clients Behind Symmetric Firewalls - A system and method for establishing and maintaining two-way peer-to-peer network communication between clients who are behind symmetric firewalls/NATs is presented (FIG. | 09-04-2008 |
Daming Feng, East Windsor, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090221555 | FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND c-MET INHIBITORS - The present invention provides a compound of formula I or II or a pharmaceutically acceptable salt form thereof, wherein R | 09-03-2009 |
Danqing Feng, Branchburg, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090105284 | Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DPP-IV inhibitors”) and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 04-23-2009 |
| 20090270467 | Aminocyclohexanes as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 10-29-2009 |
| 20100234403 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 09-16-2010 |
Danqing Feng, Green Brook, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090209544 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 08-20-2009 |
| 20100324054 | AMINOTETRAHYDROPYRANS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to novel substituted aminotetrahydropyrans of structural formula I which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 12-23-2010 |
| 20110224195 | HETEROCYCLIC COMPOUNDS AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES - The present invention is directed to substituted six-membered heterocyclic compounds of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as obesity and diabetes, particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved. | 09-15-2011 |
Guanhua Feng, Dover, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090015239 | Transmission Line Sensor - A system and method in which an overhead high voltage transmission line sensor system is able to measure one or more of temperature, current, and line sag for a conductor within a high voltage transmission line system. The sensor system may be able to clamp to a transmission conductor or splice, harvest power from the transmission line, and/or transmit data corresponding to measurements of current, temperature, and line sag. | 01-15-2009 |
| 20090086214 | ALIGNED EMBOSSED DIAPHRAGM BASED FIBER OPTIC SENSOR - The present invention is a diaphragm-fiber optic sensor (DFOS), interferometric sensor. This DFOS is based on the principles of Fabry-Perot and Michelson/Mach-Zehnder. The sensor is low cost and is designed with high efficiency, reliability, and Q-point stability, fabricated using MEMS (micro mechanic-electrical system) technology, and has demonstrated excellent performance. A DFOS according to the invention includes a cavity between two surfaces: a diaphragm made of silicon or other material with a rigid body (or boss) at the center and clamped along its edge, and the endface of a single mode optic fiber. By utilizing MEMS technology, the gap width between the diaphragm and the fiber endface is made accurately, ranging from 1 micron to 10 microns. To stabilize the Q-point of the DFOS when in use as an acoustic sensor, a system of microchannels is built in the structure of the diaphragm so that the pressure difference on two sides of the diaphragm is kept a constant, independent of the hydraulic pressure and/or low frequency noise when the device is inserted in liquid mediums. | 04-02-2009 |
Hengsheng Feng, Cherry Hill, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080220076 | Active Agent Formulations, Methods of Making, and Methods of Use - Active agent compositions comprising active agent particles having an effective average particle size of less than 2000 nm, wherein the compositions comprise a particle sequestrant are disclosed. Compositions having an effective average particle size of less than 2000 nm, wherein the compositions comprise no added surfactants, phospholipids, or combinations thereof, are also disclosed. | 09-11-2008 |
| 20090074872 | Active Agent Formulations, Methods of Making, and Methods of Use - Stable fenofibrate suspensions are disclosed herein. A fenofibrate composition includes fenofibrate nanoparticles having an average particle size of less than 500 nm, and a particle sequestrant, wherein the average particle size of the nanoparticulate suspension changes by less than 50% after standing at room temperature for 21 or more days. | 03-19-2009 |
| 20090093548 | COLCHINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 04-09-2009 |
| 20090170952 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 07-02-2009 |
| 20090215904 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 08-27-2009 |
| 20090298948 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 12-03-2009 |
| 20100159010 | Active Agent Formulations, Methods of Making, and Methods of Use - An active agent composition includes particles containing a water-insoluble active agent or an active agent with a significant food effect; and a ternary amine polymer having both hydrophobic (meth)acrylate units and acid-soluble (meth)acrylate units, and an acidifying agent; wherein upon ingestion by a human subject, the acidifying agent facilitates the dissolution of the ternary amine polymer in the gastrointestinal tract. | 06-24-2010 |
| 20110263716 | COLCHINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 10-27-2011 |
James Chi-Cheng Feng, Montvale, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100008962 | Hydrophilic Polyurethane Foam Articles Comprising an Antimicrobial Compound - Foamed polyurethane articles, such as a sponges, sheets, tapes or ribbons, blocks or other molded, extruded or cast article which foamed polyurethane articles exhibit an antimicrobial benefit and are particularly useful in the formation of cleaning articles. Processes for the manufacture of such cleaning articles based on hydrophilic polyurethane foams exhibit an antimicrobial benefit and their use are also described. | 01-14-2010 |
Lili Feng, East Hanover, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120128742 | SOLID ORAL FORMULATIONS AND CRYSTALLINE FORMS OF AN INHIBITOR OF APOPTOSIS PROTEIN - The present disclosure relates to crystalline form of (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, salts and hydrates thereof. This disclosure also relates to solid oral formulation of (S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide, pharmaceutically acceptable salts, solvates (including hydrates) thereof, as well as methods of treatment using the same. | 05-24-2012 |
Lili Feng, Pine Brook, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090131528 | SALT - The invention relates to a new salt of aliskiren, the respective production and usage, and pharmaceutical preparations containing such a salt. | 05-21-2009 |
| 20090156585 | ORGANIC COMPOUNDS - A specific combination, linked pro-drug or a compound of an angiotensin receptor antagonist and a NEPi are used in the treatment of hypertension. | 06-18-2009 |
| 20090163478 | Salts and Crystal Modifications Thereof - The invention relates to salts of 1-(2-Fluoro-phenyl)-3-(2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-urea and crystalline forms thereof, their production and usage, and pharmaceutical preparations containing such salts and crystalline forms. | 06-25-2009 |
| 20110171159 | Glycoside Derivatives and Uses Thereof - This invention relates to compounds represented by formula (I): | 07-14-2011 |
Shaolei Feng, Plainsboro, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110021915 | Detection of Structure in Ultrasound M-Mode Imaging - Automated detection of structure is provided in ultrasound M-mode imaging. A coarse and fine search for structure is used. For example, a less noise susceptible initial position or range of positions for a given structure is determined. This position is then refined. The coarse positioning and/or the refined position may use machine-trained classifiers. The positions of other structure may be used in either coarse or fine positioning, such as using a Markov Random Field. The structure or structures may be identified in the M-mode image without user input of a location in the M-mode image or along the line. | 01-27-2011 |
Sue Feng, Edison, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080199415 | COMPOSITIONS CONTAINING A BIMODAL FILM FORMER AND CROSS-LINKED STARCH - The invention relates to compositions containing (a) at least one bimodal film former; and (b) at least one cross-linked starch as well as to methods of using such compositions and kits containing such compositions. | 08-21-2008 |
| 20090136439 | COSMETIC COMPOSITION CAPABLE OF IMPARTING EXCEPTIONAL CURL-RETENTION PROPERTIES - The present invention is directed to a composition and method of making-up eyelashes involving applying onto the lashes a cosmetic composition containing: (a) at least one bimodal polymer having both anionic and cationic functionalities; (b) an aqueous microdispersion of at least one wax; (c) at least one coloring agent; (d) a physiologically suitable medium, and (e) optionally, an aqueous dispersion of at least one film-forming polymer, wherein the cosmetic composition has an average particle size of less than about 10 microns. | 05-28-2009 |
| 20090169501 | MASCARA CONTAINING A SUGAR SILICONE SURFACTANT - The invention relates to a mascara composition comprising at least one sugar silicone surfactant, as well as to methods of making and using such mascaras. | 07-02-2009 |
| 20090252698 | EMULSION COMPOSITIONS FOR EYELASHES - The invention relates to emulsion compositions for application to eyelashes containing at least one surfactant comprising silicone, hydrocarbon and glycerol group(s), as well as to methods of applying such compositions to eyelashes and kits containing such compositions. | 10-08-2009 |
| 20100043819 | COMPOSITIONS CONTAINING STIMULUS SENSITIVE COLORANT - The invention relates to compositions containing stimulus sensitive colorant as well as to methods of applying such compositions to keratin materials and kits containing such compositions. | 02-25-2010 |
| 20110086000 | NOVEL SKIN PEEL COMPOSITION IN MASQUE FORM - The present invention is directed to a method of reducing the appearance of skin changes associated with intrinsic and/or extrinsic aging, involving the steps of: (a) providing a first composition containing: (i) from about 20 to about 50% by weight of at least one hydroxy acid; (ii) optionally, from about 1 to about 15% by weight of at least one weak organic acid; and (iii) remainder, to 100%, water; (b) providing a second composition containing: (iv) from about 20 to about 50% by weight of L-ascorbic acid powder; (v) optionally, from about 1 to about 10% by weight of an extract of | 04-14-2011 |
| 20110300092 | MASCARAS OBTAINED VIA MULTI-PHASE PRODUCT - Disclosed is a multi-phase mascara product, including a first container having disposed therein a first phase comprising a wax, a second container having disposed therein a second phase comprising a film forming polymer, and a third container into which relative amounts of said first and second phases may be introduced, wherein upon mixing of the first and second phases, the third container comprises the wax, the film-forming polymer, a solvent and a thickener, wherein if the solvent and thickener are oil-soluble, they are present in the first phase, and if the solvent is aqueous and the thickener is water-soluble, they are present in the second phase. Also disclosed are methods of producing the mascara, by mixing relative amounts of the phases into a separate container. Further disclosed are methods of making up the eye lashes by application of the mascara. | 12-08-2011 |
Wei Feng, New Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120101117 | METHYLENEDIOXYBENZO [I] PHENANTHRIDINE DERIVATIVES USED TO TREAT CANCER - The invention provides compounds of formula I: wherein A, B, X, and Y have any of the values defined in the specification, as well as pharmaceutical compositions comprising such compounds, processes for preparing such compounds, and therapeutic methods for treating cancer and other topoisomerase mediated conditions. | 04-26-2012 |
Xianhong Feng, Kearny, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110237757 | Polyesters From Assymetrical Monomers Based Upon Bisanhydrohexitols - Asymmetrically substituted compounds of bisanhydrohexitols are described, including the bisanhydrohexitol isosorbide. The compounds are useful as AB monomers. The synthesis of polymers from the monomers is also described. | 09-29-2011 |
| 20110257346 | Polyester Ethers Derived From Asymmetrical Monomers Based Upon Bisanydrohexitols - Asymmetrically substituted compounds of bisanhydrohexitols are described, including the bisanhydrohexitol isosorbide. The compounds are useful as monomers. The synthesis of polymers from the monomers is also described. | 10-20-2011 |
Xidong Feng, Fair Lawn, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090105294 | Biosynthetic Gene Cluster for the Production of a Complex Polyketide - A polyketide synthase complex composed of polyketide synthase with 15 total modules, a non-ribosomal peptide synthetase with 1 module, and a cytochrome P450 hydroxylase is described. Also provided are novel | 04-23-2009 |
Yan Feng, Ridgefield, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100063141 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE - Provided are compounds having an inhibitory effect on sodium-dependent glucose cotransporter SGLT. The invention also provides pharmaceutical compositions, methods of preparing the compounds, synthetic intermediates, and methods of using the compounds, independently or in combination with other therapeutic agents, for treating diseases and conditions that are affected by SGLT inhibition. | 03-11-2010 |
Yiping Feng, North Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110076961 | Systems and Methods for Controlling the Second Order Intercept Point of Receivers - In accordance with some embodiments, methods for controlling the second order intercept point in a receiver are provided, the methods comprising: generating an amplitude modulated test tone; causing the test tone to be received by a receiver; determining a characteristic of a second order intercept point of the receiver based on the received test tone; and based on the characteristic, adjusting a parameter of the receiver. In accordance with some embodiments, systems for controlling the second order intercept point in a receiver are provided, the systems comprising: a test tone generator that generates an amplitude modulated test tone; a receiver that receives the test tone; a correlator that determines a characteristic of a second order intercept point of the receiver based on the received test tone; and digital logic that, based on the characteristic, adjusts a parameter of the receiver. | 03-31-2011 |